Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Carolyn S Lam"'
Autor:
Sebastian Göbel, Arthur Wingerter, Jürgen H. Prochaska, Andreas Schulz, Marie A. Neu, Nicole Henninger, Claudia Spix, Manfred Beutel, Karl Lackner, Thomas Münzel, Carolyn S. Lam, Hiltrud Merzenich, Jörg Faber, Philipp S. Wild
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 19 (2023)
Background The CVSS (Cardiac and Vascular Late Sequelae in Long‐Term Survivors of Childhood Cancer) study aimed to investigate the prevalence of different stages of heart failure (HF) in childhood cancer survivors (CCSs) compared with the general p
Externí odkaz:
https://doaj.org/article/34a0e504c0ab49b29c48ae0627ccd094
Autor:
Lawien Al Ali, Hilde E. Groot, Solmaz Assa, Erik Lipsic, Yoran M. Hummel, Dirk J. van Veldhuisen, Adriaan A. Voors, Iwan C. C. van der Horst, Carolyn S. Lam, Pim van der Harst
Publikováno v:
BMC Cardiovascular Disorders, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Adverse systolic remodeling after ST-elevation myocardial infarction (STEMI) is associated with poor clinical outcomes. However, little is known about diastolic remodeling. The purpose of this study was to identify the factors lea
Externí odkaz:
https://doaj.org/article/19f118b3204e4e11a23b319f7a9dc9f9
Autor:
KAMLESH KHUNTI, PETER FENICI, SUSANA GONCALVES, HIDDO L. HEERSPINK, SHASHANK JOSHI, MIKHAIL N. KOSIBOROD, CAROLYN S. LAM, ANTONIO NICOLUCCI, LARISA RAMIREZ, ALEJANDRA I. SILVA, FILIP SURMONT, HARDIK VASNAWALA, ESTEFANIA VAZQUEZ-MENDEZ
Publikováno v:
Diabetes. 71
Rationale: CRCs are known to be key determinants of patient outcomes in T2D; however, the burden of undiagnosed CRCs in unselected T2D population remains unclear, particularly in low-to-middle income countries (LMICs) . ‘Take CaRe of Me’ (TCOM) p
Autor:
Lauren B, Cooper, Jonathan, Yap, Wan Ting, Tay, Tiew-Hwa K, Teng, Michael, MacDonald, Inder S, Anand, Abhinav, Sharma, Christopher M, O'Connor, William E, Kraus, Robert J, Mentz, Carolyn S, Lam
Publikováno v:
European journal of heart failure. 20(9)
To describe differences in patient characteristics and outcomes by ethnicity in patients with diabetes mellitus (DM) and heart failure (HF) with reduced ejection fraction (HFrEF, ejection fraction ≤35%) in a multi-ethnic cohort.Patient level data f
Autor:
Lars H, Lund, Brian, Claggett, Jiankang, Liu, Carolyn S, Lam, Pardeep S, Jhund, Giuseppe M, Rosano, Karl, Swedberg, Salim, Yusuf, Christopher B, Granger, Marc A, Pfeffer, John J V, McMurray, Scott D, Solomon
Publikováno v:
European journal of heart failure. 20(8)
We tested the hypothesis that candesartan improves outcomes in heart failure (HF) with mid-range ejection fraction [HFmrEF; ejection fraction (EF) 40-49%].In 7598 patients enrolled in the CHARM Programme (HF across the spectrum of EF), we assessed ch
Autor:
Michael G, Dickinson, Carolyn S, Lam, Michiel, Rienstra, Ton E, Vonck, Yoran M, Hummel, Adriaan A, Voors, Elke S, Hoendermis
Publikováno v:
European journal of heart failure. 19(11)
During right heart catheterization, pulmonary artery wedge pressure (PAWP) is often assumed to reflect left ventricular filling pressure. We sought to determine the impact of atrial fibrillation (AF) on the relationship between PAWP and left ventricu
Autor:
Miguel M Fernandes-Silva, Amil M Shah, Sheila M Hegde, Alexandra Goncalves, Brian Claggett, Susan Cheng, Wilson Nadruz, Carolyn S Lam, Barry A Borlaug, Scott D Solomon
Publikováno v:
Circulation. 132
Introduction: The incidence of heart failure (HF) is higher in black than in white Americans, but the causes are unclear. We proposed that ethnic differences in ventricular-arterial interaction may contribute to this differential HF risk. Methods: We
Autor:
Javed, Butler, Gregg C, Fonarow, Michael R, Zile, Carolyn S, Lam, Lothar, Roessig, Erik B, Schelbert, Sanjiv J, Shah, Ali, Ahmed, Robert O, Bonow, John G F, Cleland, Robert J, Cody, Ovidiu, Chioncel, Sean P, Collins, Preston, Dunnmon, Gerasimos, Filippatos, Martin P, Lefkowitz, Catherine N, Marti, John J, McMurray, Frank, Misselwitz, Savina, Nodari, Christopher, O'Connor, Marc A, Pfeffer, Burkert, Pieske, Bertram, Pitt, Giuseppe, Rosano, Hani N, Sabbah, Michele, Senni, Scott D, Solomon, Norman, Stockbridge, John R, Teerlink, Vasiliki V, Georgiopoulou, Mihai, Gheorghiade
Publikováno v:
JACC. Heart failure, vol 2, iss 2
The burden of heart failure with preserved ejection fraction (HFpEF) is considerable and is projected to worsen. To date, there are no approved therapies available for reducing mortality or hospitalizations for these patients. The pathophysiology of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5be7ba8aabc0139d9554438b74f330f9
https://escholarship.org/uc/item/582686tc
https://escholarship.org/uc/item/582686tc
Autor:
Alessandro Cataliotti, Richard J Rodeheffer, Douglas W Mahoney, Carolyn S Lam, Margaret M Redfield, Fernando L Martin, John C Burnett
Publikováno v:
Circulation. 118
Background: Chronic renal insufficiency (CRI) is a strong predictor of increased mortality in the presence of heart failure (HF) and its prevalence has been increasing in the US. In addition, CRI is a major contributing factor to the progression of H
Publikováno v:
Circulation. 118
Background Patients with heart failure and preserved ejection fraction (HFpEF) have diastolic dysfunction, but are traditionally considered to have normal left ventricular (LV) systolic function. However, ventricular remodeling can result in preserva